Moreover, soluble PD-L1 did not correlate with disease progression in patients with metastatic gastric cancer, HNSCC, or NSCLC (Liu et al., 2018b; Fan et al., 2019; Li et al., 2019a; Pang et al., 2020). This evidence concerns the gene CD274 and non-small cell lung carcinoma.